LGM Pharma

Teriflunomide

CAS No: 163451-81-8

Teriflunomide

LGM Pharma is a Teriflunomide 163451-81-8 active pharmaceutical ingredient supplier, based in the USA.

Questions? Call our customer API support number 1-(800)-881-8210.

LGM Pharma offers this active ingredient but not the finished dosage forms.

Inquire about Teriflunomide

Product Details:

CAS No: 163451-81-8
Synonyms: (Z)-2-cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-p-crotonotoluidide, A 1726, A 77-1726, A 771726, Aubagio, Flucyamide, HMR 1726, HMR1726, SU 20, Teriflunomide, UNII-1C058IKG3B
Molecular Weight: 270.207 g/mol
PubChem: 5479847
Chemical Formula: C12H9N2O2
Assay/Purity: Typically NLT 98%
IUPAC Name: 2-Butenamide, 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-, (Z)-
SMILES: c1c(ccc(c1)C(F)(F)F)NC(=O)/C(=C(/C)O)C#N
InChl: 1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-

Teriflunomide News:

  • On November 22, 2013 Health Canada approved the novel once daily pill Teriflunomide for the treatment of Multiple Sclerosis.
  • Teriflunomide was approved by the FDA in September of 2012 for the treatment of patients with relapsing remitting multiple sclerosis, or RRMS.
  • Multiple sclerosis has recently been in the spotlight worldwide with Jack Osborne, son of Ozzy Osborne performing on Dancing with the Stars. Jack suffers from MS.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.